Abiopharma

🔍 Dalto Juan Carlos (Director)

Company: Lifeway Foods, Inc. (LWAY)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-31 | Code: H | shares_owned_after: 4,751.00
• Sold 1,550 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-31 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F3, F3
• Acquired 1,550 shares of Phantom Stock (Derivative)
  Date: 2026-08-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 10,771.00 | transaction_form_type: 4 | Footnotes: F6, F6, F6, F6
• Holds 2,512 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-31 | Code: H | shares_owned_after: 2,512.00 | Footnotes: F1, F2, F2
• Holds 1,354 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-31 | Code: H | shares_owned_after: 1,354.00 | Footnotes: F1, F4, F4
• Holds 2,038 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-31 | Code: H | shares_owned_after: 2,038.00 | Footnotes: F1, F5, F5

Footnotes:

• F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
• F2: The RSUs vest on December 30, 2026 contingent on the Reporting Person's continued service as a Director on such vesting date.
• F3: The RSUs vested on August 31, 2026.
• F4: The RSUs vest on July 1, 2027, contingent on the Reporting Person's continued service as a Director on such vesting date.
• F5: The RSUs vest on July 1, 2027, contingent on the Reporting Person's continued service as a Director on such vesting date.
• F6: Each share of phantom stock represents a right to receive one share of common stock. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company.
• F7: In connection with the vesting on August 31, 2026 of RSUs previously granted to the Reporting Person, the Reporting Person's receipt of 1,550 shares of common stock was deferred resulting in the Reporting Person's receipt instead of 1,550 shares of phantom stock pursuant to the Company's Non-Employee Director Equity and Deferred Compensation Plan. The Reporting Person is therefore reporting the disposition of 1,550 RSUs in exchange for an equal number of shares of phantom stock.